Atea Pharmaceuticals, Inc. (AVIR) Total Assets by Year
Atea Pharmaceuticals, Inc. closed fiscal year 2025 with $315.2M in total assets, $39.8M in total liabilities and $275.4M in shareholder equity. This represents a decrease of 32.2% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Atea Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AVIR Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY22DEF 14A | FY2110-K | FY2010-K | FY1910-K | FY1810-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $315.2M-32.2% | $464.7M-21.9% | $595.0M-10.8% | $666.7M-13.7% | $772.9M-10.5% | $863.6M+3812.6% | $22.1M | N/A |
| Total Liabilities | $39.8M+54.2% | $25.8M-35.1% | $39.8M+52.2% | $26.1M-58.4% | $62.8M-80.1% | $315.8M+340.8% | $71.6M | N/A |
| Total Equity | $275.4M-37.2% | $438.9M-21.0% | $555.2M-13.3% | $640.6M-9.8% | $710.1M+29.6% | $547.8M+1205.1% | -$49.6M-37.1% | -$36.2M |
AVIR Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $232.3M-40.7% | $267.1M-39.3% | $315.2M-32.2% | $343.0M-30.1% | $391.6M-23.3% | $440.0M-20.4% | $464.7M-21.9% | $491.0M-19.3% | $510.4M-18.5% | $553.0M-13.3% | $595.0M-10.8% | $608.1M-11.4% |
| Total Liabilities | $28.1M+3.4% | $33.4M+15.5% | $39.8M+54.2% | $27.2M-16.2% | $27.2M-19.8% | $28.9M-40.6% | $25.8M-35.1% | $32.4M+23.1% | $33.9M+43.2% | $48.7M+143.9% | $39.8M+52.2% | $26.3M+12.6% |
| Total Equity | $204.2M-44.0% | $233.7M-43.1% | $275.4M-37.2% | $315.8M-31.1% | $364.4M-23.5% | $411.1M-18.5% | $438.9M-21.0% | $458.5M-21.2% | $476.5M-20.9% | $504.4M-18.4% | $555.2M-13.3% | $581.7M-12.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Atea Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Atea Pharmaceuticals, Inc.'s total assets in fiscal year 2025?
Atea Pharmaceuticals, Inc. closed fiscal year 2025 with $315.2M in total assets, $39.8M in total liabilities and $275.4M in shareholder equity.
How fast is Atea Pharmaceuticals, Inc.'s total assets growing?
Atea Pharmaceuticals, Inc. (AVIR) total assets fell by 32.2% year over year, from $464.7M to $315.2M in fiscal year 2025.
What was Atea Pharmaceuticals, Inc.'s total assets in the most recent quarter?
Atea Pharmaceuticals, Inc. (AVIR) reported $232.3M in total assets in Q2 2026. This represents a decrease of 40.7% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Atea Pharmaceuticals, Inc. (AVIR) reported on that line in every period on record.